title: Diffuse hyperpigmented plaques as cutaneous manifestation of multicentric Castleman disease and treatment with thalidomide: report of three cases.
authors.affiliation: Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
authors.forename: Xiaoqing
authors.initials: X
authors.lastname: Zhao
authors.affiliation: Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
authors.forename: Ruofei
authors.initials: R
authors.lastname: Shi
authors.affiliation: Department of Pathology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
authors.forename: Xiaolong
authors.initials: X
authors.lastname: Jin
authors.affiliation: Department of Dermatology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China. Electronic address: jie-zheng2001@126.com.
authors.forename: Jie
authors.initials: J
authors.lastname: Zheng
mesh_terms: D000328:Adult; D001707:Biopsy, Needle; D005871:Castleman Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology*; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017495:Hyperpigmentation / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology*; D007150:Immunohistochemistry; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D018570:Risk Assessment; D012494:Sampling Studies; D012720:Severity of Illness Index; D013792:Thalidomide / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D013792:Thalidomide; D011241:Prednisone